{"id":"NCT02952898","sponsor":"Balmoral Medical company","briefTitle":"Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-10-27","primaryCompletion":"2017-07-11","completion":"2017-09-06","firstPosted":"2016-11-02","resultsPosted":"2019-01-10","lastUpdate":"2020-01-07"},"enrollment":665,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratosis"],"interventions":[{"type":"DRUG","name":"GDC 695","otherNames":[]},{"type":"DRUG","name":"Diclofenac Sodium Gel, 3%","otherNames":[]},{"type":"DRUG","name":"Vehicle gel","otherNames":[]}],"arms":[{"label":"Test Drug","type":"EXPERIMENTAL"},{"label":"Reference Drug","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This research study is being done to compare the safety and effectiveness of GDC 695 (test drug) against the currently marketed reference drug (diclofenac sodium gel, 3%) and to establish that these two drugs work better than placebo in the treatment of actinic keratosis.","primaryOutcome":{"measure":"Number of Subjects With Complete Clearance of AK Lesions","timeFrame":"Day 90 (30 days after completion of 60 days of treatment)","effectByArm":[{"arm":"GDC 695 Gel","deltaMin":30.2,"sd":null},{"arm":"Diclofenac Sodium Gel","deltaMin":25.7,"sd":null},{"arm":"Placebo","deltaMin":9.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":17},"locations":{"siteCount":16,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":218},"commonTop":["Upper respiratory tract infection","Application site erythema","Sinusitis","Application site oedema","Application site pain"]}}